^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PROSTest®

    Company:
    Wren Laboratories
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    4d
    Clinical Utility of PROSTest: A Prospective Study Suggesting Reduction in Unnecessary MRI and Biopsy in Men Evaluated for Prostate Cancer. (PubMed, Cancers (Basel))
    Among men without a detectable prostate cancer on biopsy, 47% (8/17) were PROSTest-negative. These results suggest that PROSTest may serve as a useful pre-biopsy triage assay.
    Journal
    |
    PROSTest®
    11d
    PROSTest_STRAT: A Prospective Clinical Trial Evaluating PROSTest, a Blood-Based Molecular Assay, for Risk Stratification and Biopsy Decision Support in Men With Suspected Prostate Cancer (clinicaltrials.gov)
    P=N/A, N=1500, Not yet recruiting, Wren Laboratories LLC
    New trial
    |
    PROSTest®